Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitusShusuke Yagi, Masataka Sata, Hirotsugu Yamada et al.|Diabetology & Metabolic Syndrome|2017Cited by 187
Predictors for the Treatment Effect of Sodium Glucose Co-transporter 2 Inhibitors in Patients with Type 2 Diabetes MellitusShusuke Yagi, Masataka Sata, Ken‐ichi Aihara et al.|Advances in Therapy|2017Cited by 13